发明公开
- 专利标题： AMINOACYL-PRODRUG DERIVATE UND ARZNEIMITTEL ZUR BEHANDLUNG VON THROMBOEMBOLISCHEN ERKRANKUNGEN
- 专利标题（英）： Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
- 专利标题（中）： 氨前体药物衍生物及药物来治疗疾病血栓栓塞
-
申请号： EP07703379.3申请日： 2007-02-06
-
公开(公告)号： EP1987026A1公开(公告)日： 2008-11-05
- 发明人: LERCHEN, Hans-Georg , KRENZ, Ursula , SCHLEMMER, Karl-Heinz , PERZBORN, Elisabeth , KELDENICH, Joerg
- 申请人： Bayer HealthCare AG
- 申请人地址： 51368 Leverkusen DE
- 专利权人： Bayer HealthCare AG
- 当前专利权人： Bayer HealthCare AG
- 当前专利权人地址： 51368 Leverkusen DE
- 优先权： DE102006007146 20060216
- 国际公布： WO2007093328 20070823
- 主分类号： C07D413/14
- IPC分类号： C07D413/14 ; A61P7/02 ; A61K31/422
摘要：
The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-morpholin-4-yl)phenyl]-l,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolitic disorders.
公开/授权文献
信息查询
